BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

714 related articles for article (PubMed ID: 9893992)

  • 1. Binding specificity and modulation of the human ApoCIII promoter activity by heterodimers of ligand-dependent nuclear receptors.
    Lavrentiadou SN; Hadzopoulou-Cladaras M; Kardassis D; Zannis VI
    Biochemistry; 1999 Jan; 38(3):964-75. PubMed ID: 9893992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transactivation of the human apolipoprotein CII promoter by orphan and ligand-dependent nuclear receptors. The regulatory element CIIC is a thyroid hormone response element.
    Kardassis D; Sacharidou E; Zannis VI
    J Biol Chem; 1998 Jul; 273(28):17810-6. PubMed ID: 9651383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulation of human apolipoprotein genes ApoB, ApoCIII, and ApoAII by members of the steroid hormone receptor superfamily HNF-4, ARP-1, EAR-2, and EAR-3.
    Ladias JA; Hadzopoulou-Cladaras M; Kardassis D; Cardot P; Cheng J; Zannis V; Cladaras C
    J Biol Chem; 1992 Aug; 267(22):15849-60. PubMed ID: 1639815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergism between nuclear receptors bound to specific hormone response elements of the hepatic control region-1 and the proximal apolipoprotein C-II promoter mediate apolipoprotein C-II gene regulation by bile acids and retinoids.
    Kardassis D; Roussou A; Papakosta P; Boulias K; Talianidis I; Zannis VI
    Biochem J; 2003 Jun; 372(Pt 2):291-304. PubMed ID: 12585964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding specificity and modulation of the ApoA-I promoter activity by homo- and heterodimers of nuclear receptors.
    Tzameli I; Zannis VI
    J Biol Chem; 1996 Apr; 271(14):8402-15. PubMed ID: 8626539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism between apolipoprotein AI regulatory protein 1, Ear3/COUP-TF, and hepatocyte nuclear factor 4 modulates apolipoprotein CIII gene expression in liver and intestinal cells.
    Mietus-Snyder M; Sladek FM; Ginsburg GS; Kuo CF; Ladias JA; Darnell JE; Karathanasis SK
    Mol Cell Biol; 1992 Apr; 12(4):1708-18. PubMed ID: 1312668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex interactions between SP1 bound to multiple distal regulatory sites and HNF-4 bound to the proximal promoter lead to transcriptional activation of liver-specific human APOCIII gene.
    Talianidis I; Tambakaki A; Toursounova J; Zannis VI
    Biochemistry; 1995 Aug; 34(32):10298-309. PubMed ID: 7640286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional regulation of the apolipoprotein A-IV gene involves synergism between a proximal orphan receptor response element and a distant enhancer located in the upstream promoter region of the apolipoprotein C-III gene.
    Ktistaki E; Lacorte JM; Katrakili N; Zannis VI; Talianidis I
    Nucleic Acids Res; 1994 Nov; 22(22):4689-96. PubMed ID: 7984419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The directly repeated RG(G/T)TCA motifs of the rat and mouse cellular retinol-binding protein II genes are promiscuous binding sites for RAR, RXR, HNF-4, and ARP-1 homo- and heterodimers.
    Nakshatri H; Chambon P
    J Biol Chem; 1994 Jan; 269(2):890-902. PubMed ID: 8288643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional specificity of two hormone response elements present on the human apoA-II promoter that bind retinoid X receptor alpha/thyroid receptor beta heterodimers for retinoids and thyroids: synergistic interactions between thyroid receptor beta and upstream stimulatory factor 2a.
    Hatzivassiliou E; Koukos G; Ribeiro A; Zannis V; Kardassis D
    Biochem J; 2003 Dec; 376(Pt 2):423-31. PubMed ID: 12959642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transactivation of the ApoCIII promoter by ATF-2 and repression by members of the Jun family.
    Hadzopoulou-Cladaras M; Lavrentiadou SN; Zannis VI; Kardassis D
    Biochemistry; 1998 Oct; 37(40):14078-87. PubMed ID: 9760243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dynamic balance between ARP-1/COUP-TFII, EAR-3/COUP-TFI, and retinoic acid receptor:retinoid X receptor heterodimers regulates Oct-3/4 expression in embryonal carcinoma cells.
    Ben-Shushan E; Sharir H; Pikarsky E; Bergman Y
    Mol Cell Biol; 1995 Feb; 15(2):1034-48. PubMed ID: 7823919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional domains of the human orphan receptor ARP-1/COUP-TFII involved in active repression and transrepression.
    Achatz G; Hölzl B; Speckmayer R; Hauser C; Sandhofer F; Paulweber B
    Mol Cell Biol; 1997 Sep; 17(9):4914-32. PubMed ID: 9271371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The retinoid X receptor response element in the human aldehyde dehydrogenase 2 promoter is antagonized by the chicken ovalbumin upstream promoter family of orphan receptors.
    Pinaire J; Hasanadka R; Fang M; Chou WY; Stewart MJ; Kruijer W; Crabb D
    Arch Biochem Biophys; 2000 Aug; 380(1):192-200. PubMed ID: 10900149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A short proximal promoter and the distal hepatic control region-1 (HCR-1) contribute to the liver specificity of the human apolipoprotein C-II gene. Hepatic enhancement by HCR-1 requires two proximal hormone response elements which have different binding specificities for orphan receptors HNF-4, ARP-1, and EAR-2.
    Vorgia P; Zannis VI; Kardassis D
    J Biol Chem; 1998 Feb; 273(7):4188-96. PubMed ID: 9461615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distal apolipoprotein C-III regulatory elements F to J act as a general modular enhancer for proximal promoters that contain hormone response elements. Synergism between hepatic nuclear factor-4 molecules bound to the proximal promoter and distal enhancer sites.
    Kardassis D; Tzameli I; Hadzopoulou-Cladaras M; Talianidis I; Zannis V
    Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):222-32. PubMed ID: 9012660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultraspiracle, a Drosophila retinoic X receptor alpha homologue, can mobilize the human thyroid hormone receptor to transactivate a human promoter.
    Hatzivassiliou E; Cardot P; Zannis VI; Mitsialis SA
    Biochemistry; 1997 Jul; 36(30):9221-31. PubMed ID: 9230055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression.
    Claudel T; Inoue Y; Barbier O; Duran-Sandoval D; Kosykh V; Fruchart J; Fruchart JC; Gonzalez FJ; Staels B
    Gastroenterology; 2003 Aug; 125(2):544-55. PubMed ID: 12891557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A corepressor and chicken ovalbumin upstream promoter transcriptional factor proteins modulate peroxisome proliferator-activated receptor-gamma2/retinoid X receptor alpha-activated transcription from the murine lipoprotein lipase promoter.
    Robinson CE; Wu X; Nawaz Z; Onãte SA; Gimble JM
    Endocrinology; 1999 Apr; 140(4):1586-93. PubMed ID: 10098492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of liver-enriched transcription factors and nuclear receptors in regulating the human, mouse, and rat NTCP gene.
    Jung D; Hagenbuch B; Fried M; Meier PJ; Kullak-Ublick GA
    Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G752-61. PubMed ID: 14701722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.